S M Verstappen

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. ncbi The Utrecht experience with different treatment strategies in early rheumatoid arthritis
    S M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Clin Exp Rheumatol 21:S165-8. 2003
  2. pmc A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:38-43. 2005
  3. ncbi Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    Arthritis Rheum 51:488-97. 2004
  4. pmc Determinants of direct costs in Dutch rheumatoid arthritis patients
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 63:817-24. 2004
  5. ncbi Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Rheumatology (Oxford) 44:202-6. 2005
  6. pmc Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:1754-60. 2005
  7. pmc Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherlands
    Arthritis Res Ther 8:R31. 2006
  8. ncbi Trends in economic consequences of rheumatoid arthritis over two subsequent years
    S M M Verstappen
    University Medical Center Utrecht, The Netherlands
    Rheumatology (Oxford) 46:968-74. 2007
  9. pmc Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
    S M M Verstappen
    University Medical Center Utrecht, Utrecht, The Netherlands
    Ann Rheum Dis 66:1443-9. 2007
  10. pmc Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 65:1506-11. 2006

Detail Information

Publications14

  1. ncbi The Utrecht experience with different treatment strategies in early rheumatoid arthritis
    S M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Clin Exp Rheumatol 21:S165-8. 2003
    ..We therefore conclude that MTX is the DMARD of first choice and that treatment should be tailored to the individual patient...
  2. pmc A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:38-43. 2005
    ..To describe the frequency and duration of remission in the Utrecht rheumatoid arthritis cohort of patients followed since diagnosis, and the clinical and treatment characteristics of patients with remission v those without...
  3. ncbi Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    Arthritis Rheum 51:488-97. 2004
  4. pmc Determinants of direct costs in Dutch rheumatoid arthritis patients
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 63:817-24. 2004
    ....
  5. ncbi Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Rheumatology (Oxford) 44:202-6. 2005
    ..To assess work disability and variables associated with work disability among Dutch patients with rheumatoid arthritis (RA)...
  6. pmc Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:1754-60. 2005
    ..To assess productivity costs incurred by rheumatoid arthritis, comprising paid as well as household productivity costs, from a societal perspective, using different methods...
  7. pmc Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherlands
    Arthritis Res Ther 8:R31. 2006
    ....
  8. ncbi Trends in economic consequences of rheumatoid arthritis over two subsequent years
    S M M Verstappen
    University Medical Center Utrecht, The Netherlands
    Rheumatology (Oxford) 46:968-74. 2007
    ..To examine changes in direct costs and in working status over 2 yrs in patients with rheumatoid arthritis (RA)...
  9. pmc Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
    S M M Verstappen
    University Medical Center Utrecht, Utrecht, The Netherlands
    Ann Rheum Dis 66:1443-9. 2007
    ..To investigate whether intensive treatment with methotrexate (MTX) according to a strict protocol and a computerised decision program is more beneficial compared to conventional treatment with MTX in early rheumatoid arthritis...
  10. pmc Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 65:1506-11. 2006
    ....
  11. pmc Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 66:727-31. 2007
    ..To compare utility and disease-specific direct costs between patients with ankylosing spondylitis (AS) and patients with rheumatoid arthritis (RA) in the Netherlands...
  12. pmc Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
    M F Bakker
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 66:iii56-60. 2007
    ..Tight control is a treatment strategy tailored to the individual patient with RA, which aims to achieve a predefined level of low disease activity or remission within a certain period of time...
  13. doi Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 69:1044-8. 2010
    ....
  14. doi Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis
    J N Hoes
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 68:1833-8. 2009
    ..To systematically analyse the literature on reported adverse events of low- to medium-dose glucocorticoids during >or=1 month for inflammatory diseases...